ResearcherCarl von Ossietzky Universität OldenburgActive in the last 2 years

Christin Knickmeier

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 8 November 2026

Matched on OpenAlex author ID A5116108940. Sources: OpenAlex.

Their work

Papers: 1
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 4

Papers, trials and grants by year

2025: 1 paper

Papers 1

It's about TIME - Gal-9 as a potential immunotherapeutic target in pancreatic ductal adenocarcinoma. Co-author DOI 10.3389/fimmu.2025.1495907 ↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Maarten W. Nijkamp · 1 shared paper, 2025 · strength 0.28
- Paper It's about TIME - Gal-9 as a potential immunotherapeutic target in pancreatic ductal adenocarcinoma. DOI 10.3389/fimmu.2025.1495907 ↗
Maximilian Bockhorn · 1 shared paper, 2025 · strength 0.28
- Paper It's about TIME - Gal-9 as a potential immunotherapeutic target in pancreatic ductal adenocarcinoma. DOI 10.3389/fimmu.2025.1495907 ↗
N. Helge Meyer · 1 shared paper, 2025 · strength 0.28
- Paper It's about TIME - Gal-9 as a potential immunotherapeutic target in pancreatic ductal adenocarcinoma. DOI 10.3389/fimmu.2025.1495907 ↗
Gaetan Aime Noubissi Nzeteu · 1 shared paper, 2025 · strength 0.28
- Paper It's about TIME - Gal-9 as a potential immunotherapeutic target in pancreatic ductal adenocarcinoma. DOI 10.3389/fimmu.2025.1495907 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.